Janssen/MeiraGTx showcase nine-month data for sight loss gene therapy by Lucy Parsons | Oct 5, 2020 | News | 0 Gene therapy demonstrated improvement in retinal sensitivity Read More
Janssen/MeiraGTx sight loss gene therapy hits targets by Selina McKee | Jul 20, 2020 | News | 0 Interim six-month data of RPGR gene therapy shows significant vision improvement in patients with X-linked retinitis pigmentosa Read More
Janssen and MeiraGTx team up to fight inherited retinal diseases by Anna Smith | Jan 31, 2019 | News | 0 MeiraGTx has announced a strategic collaboration with Johnson & Johnson’s Janssen to develop and commercialise gene therapy treatments for inherited retinal diseases (IRDs). Read More